Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
67.53
+4.21 (6.65%)
At close: May 12, 2025, 4:00 PM
66.55
-0.98 (-1.45%)
After-hours: May 12, 2025, 7:48 PM EDT
Verona Pharma Revenue
Verona Pharma had revenue of $76.26M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $118.54M. In the year 2024, Verona Pharma had annual revenue of $42.28M.
Revenue (ttm)
$118.54M
Revenue Growth
n/a
P/S Ratio
47.05
Revenue / Employee
$567,153
Employees
209
Market Cap
6.15B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
VRNA News
- 6 days ago - Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025 - GlobeNewsWire
- 11 days ago - Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster - Seeking Alpha
- 13 days ago - Verona Pharma plc (VRNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical - Seeking Alpha
- 6 weeks ago - Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS - GlobeNewsWire
- 2 months ago - Verona Pharma plc (VRNA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire